SCHEMBL25556331

SCHEMBL25556331

C=C(OC)c1ccc(F)cc1NC(=O)CCC(=O)OC

nearest known ligand 0.49

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.49
▸ POLB P06746 1/20 0.49
▸ HSD17B10 Q99714 2/20 0.46
▸ MAPT P10636 2/20 0.46
▸ CYP1A2 P05177 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ TP53 P04637 1/20 0.44
▸ HPGD P15428 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ PTPRC P08575 2/20 0.42
▸ PTPN13 Q12923 2/20 0.42
▸ CTSL P07711 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31058565 0.86 ALDH1A1 (0.58) ALDH1A1POLBHSD17B10MAPTCYP1A2
SCHEMBL25555717 0.86 ALDH1A1 (0.58) ALDH1A1POLBHSD17B10MAPTCYP1A2
SCHEMBL25556511 0.78 ALDH1A1 (0.51) ALDH1A1POLBHSD17B10MAPTCYP1A2
SCHEMBL30587103 0.78 ALDH1A1 (0.51) ALDH1A1POLBHSD17B10MAPTCYP1A2
SCHEMBL21794443 0.77 ALDH1A1 (0.50) ALDH1A1POLBHSD17B10MAPTCYP1A2
SCHEMBL26317015 0.73 CES2 (0.47) ALDH1A1HSD17B10MAPTLMNAHTT
SCHEMBL29783185 0.71 HSD17B10 (0.63) ALDH1A1POLBHSD17B10MAPTCYP1A2
SCHEMBL12217649 0.71 HSD17B10 (0.63) ALDH1A1POLBHSD17B10MAPTCYP1A2
SCHEMBL20339548 0.71 KDM4E (0.51) ALDH1A1POLBHSD17B10CYP2C19HPGD
SCHEMBL29902945 0.71 KDM4E (0.51) ALDH1A1POLBHSD17B10CYP2C19HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023088420-A1 1H-BENZO[B]AZEPIN-2(3H)-ONE COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING CANCER Chengdu Anticancer Bioscience, Ltd. (CN) 2023-05-25 — — WO disclosed
Send feedback